Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-01-12 12:02 |
Valneva in Advanced Discussions with European Commission to Supply up to 60 Mil…
|
English | 411.9 KB | ||
| 2021-01-12 12:02 |
Valneva en discussions avancées avec la Commission Européenne pour fournir jusq…
|
French | 676.8 KB | ||
| 2021-01-11 07:00 |
Valneva renforce ses équipes dirigeantes et nomme Perry Celentano comme COO int…
|
French | 311.6 KB | ||
| 2021-01-11 07:00 |
Valneva Strengthens Management Team; Appoints Perry Celentano as Interim COO an…
|
English | 307.0 KB | ||
| 2021-01-08 18:00 |
VALNEVA - Déclaration d’actions et de droits de vote – DECEMBRE 2020
|
French | 205.8 KB | ||
| 2021-01-08 18:00 |
Bilan Semestriel du contrat de liquidité de Valneva SE
|
French | 405.7 KB | ||
| 2021-01-07 17:45 |
Valneva annonce une trésorerie de plus de €200 millions à fin 2020
|
French | 409.5 KB | ||
| 2021-01-07 17:45 |
Valneva Reports FY 2020 Cash of Over €200 Million
|
English | 409.1 KB | ||
| 2020-12-22 17:45 |
Valneva Shareholders Approve EGM Resolutions to Support Potential US IPO Plan
|
English | 306.6 KB | ||
| 2020-12-22 17:45 |
Les actionnaires de Valneva approuvent les résolutions permettant une possible …
|
French | 307.9 KB | ||
| 2020-12-16 07:00 |
Valneva initie une étude clinique de Phase 1/2 pour son candidat vaccin inactiv…
|
French | 756.0 KB | ||
| 2020-12-16 07:00 |
Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 …
|
English | 317.1 KB | ||
| 2020-12-15 11:40 |
Franchissement de seuil
|
French | 195.3 KB | ||
| 2020-12-07 15:00 |
Valneva annonce la modification des modalités de participation à son Assemblée …
|
French | 381.5 KB | ||
| 2020-12-07 15:00 |
Valneva Announces the Modification of the Conditions of Participation in its Ex…
|
English | 314.1 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
